Pregnancy Hypertension-An International Journal of Womens Cardiovascul

Article	Citations
Comparison of subfoveal choroidal thickness in patients with hypertensive disorder of pregnancy versus normotensive pregnant women in third trimester of pregnancy	661
GSTP1-A313G genetic polymorphism and the risk of preeclampsia in pregnant women: A study in the northern population of Iran	155
Cardiometabolic health 8–12 years after pre-eclampsia: Role of obesity and gestational diabetes (FINNCARE study)	45
New 3D cardiac in vitro models for assessing the maternal cardiovascular health five years post hypertensive disorders of pregnancy	37
Six-week blood pressure trends in postpartum patients utilizing remote patient monitoring program	29
Perceptions and experiences of blood pressure self-monitoring during hypertensive pregnancy: A qualitative analysis of women’s and clinicians’ experiences in the OPTIMUM-BP trial	24
OP15_4. A biopolymer-fused form of placental growth factor for treatment of preeclampsia	23
PO6_19. The diagnostic accuracy of American college of cardiology/American heart association blood pressure categories for identification of women and babies at risk of adverse pregnancy outcomes – a	22
Alterations in the metabolic status of amino acids in newborns of pre-eclampsia women	21
Sociodemographic risk factors associated with patient follow-up after implementation of a CardioObstetrics program	19
Examining changes in clinical management and postpartum readmissions for hypertensive disorders of pregnancy over time	19
PO8_1. CANCELLED : Predictive value of longitudinal maternal serum angiogenic marker assessment for maternal adverse outcomes in pregnancies with preeclampsia	18
Comparison of Zuspan regimen and its 12-hour modification in women with severe pre-eclampsia and eclampsia in two hospitals in Abeokuta	17
PO1_20. Midtrimester drop in bp is not associated with a decreased risk for hypertensive disorder of pregnancy in a nulliparous cohort	17
OP14_5. Metformin to prolong pregnancy in preterm preeclampsia	16
PO6_15. Predictive utility for preeclampsia of the SFLT-1/PLGF ratio test in routine clinical practice: a retrospective analysis of 1,397 pregnancies with suspected pre-eclampsia	16
Association of MTHFR C677T and A1298C variants with preeclampsia risk and angiogenic imbalance in Tunisian women	16
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to lett	16
Management of hypertension in the early postpartum: A randomized controlled trial	15
Short communication: Is there any benefit of initiating aspirin before the 11th week of gestation?	14
Extended postpartum outcomes with systematic treatment of and management of postpartum hypertension program	14
Reduced urinary angiotensinogen excretion in preeclampsia	14
The sFLT-1/PlGF ratio versus biochemical parameters in prediction of adverse outcomes in preeclamptic women	14
PO2_08. decreased sodium (NA + ) buffer capacity in pregnancy and in women following pre-eclampsia	13
Letter to the editor: Detection of hypertension and blood pressure phenotypes using ambulatory blood pressure monitoring in women with past hypertensive disorders of pregnancies	13

Response to letter to the editor	13
Conformation-dependent anti-Aβ monoclonal antibody signatures of disease status and severity in urine of women with preeclampsia	13
PO7_3. Patient perception of home blood pressure monitoring kits	13
Diagnostic accuracy of urine dipstick tests for proteinuria in pregnant women suspected of preeclampsia: A systematic review and meta-analysis	13
Peripartum antihypertensive use and the risk of neonatal hypoglycemia and postpartum uterine atony: a retrospective cohort study	12
The P4 Study: 6 months postpartum body composition in normotensive vs hypertensive pregnancies	12
Case of chorioamnionitis in ANA positive in second trimester of pregnancy	11
Validation of the fullPIERS model in a tertiary hospital in southern Brazil	11
Association between serum NfL and NfH with Antepartum and Postpartum Hypertension	10
Proteinuria in severe preeclampsia: Clinical significance in modern obstetrics	10
Home blood pressure monitoring and mobile health application practices among pregnant persons with and at risk of hypertensive disorders of pregnancy	10
Neuroimaging in eclampsia: A window into the correlates between neural pathology and maternal outcomes	10
Validation of urinary Congo Red preeclampsia detection point-of-care devise	10
Effect of positioning on blood pressure measurement in pregnancy	10
Rubidium – Initial observations of an enigmatic element in pre-eclampsia	10
Smaller decrease in late second trimester blood pressure is associated with gestational hypertensive disease development	10
WITHDRAWN: COVID-19 not hypertension or diabetes increases the risk of preeclampsia among a high-risk population	10
OP14_4. Epigenetic regulation by STOX1 in trophoblast cells lines	9
Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsia	9
Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study	9
PO9_05. Endothelial glycocalyx dysfunction in early- and late-onset preeclampsia	9
Perinatal outcomes and their determinants among women with eclampsia and severe preeclampsia in selected tertiary hospitals, Eastern Ethiopia	9
PO4_2. Genome-wide association study sheds more light on the pathophysiology of preeclampsia	9
PO7_1. Patient perceptions regarding remote patient monitoring for postpartum hypertension	9
Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia	8
PO6_06. Soluble endoglin versus SFLT-1/PLGF ratio: detection of preeclampsia, hellp syndrome and FGR in a high-risk cohort	8
Nifedipine outperforms labetalol: A comparative analysis of hypertension management in black pregnancies	8
Determining the relationship between severity of proteinuria and adverse maternal and neonatal outcomes in patients with preeclampsia	8
Secondary hyperaldosteronism due to renal agenesis: Rare cause of secondary hypertension in pregnancy	8
Comparison of double-filtration plasmapheresis (DFPP) versus heparin-mediated extracorporeal LDL-precipitation (HELP)-apheresis in early-onset preeclampsia	8
PO2_14. Impact of previous hypertensive disorders during pregnancy on long-term cardiovascular consequences in women with severe hypertension	8
History of IgA vasculitis with nephropathy (Henoch-Schonlein purpura nephritis) can be a strong risk factor for preeclampsia	8
The unintended consequences of modernity: Pollution and its effect on reproductive, maternal and fetal health	8
Perfluorooctane sulfonic acid increases blood pressure and disrupts vascular function and placental steroidogenesis in pregnant rats	8
PO6_21. The utility of the SFLT-1/PLGF ratio among patients with or without hypertension who are suspected of having preeclampsia	7
Validation of the Finnish Care register for Health Care diagnoses for preeclampsia, gestational diabetes and preterm delivery	7
Maternal bradycardia heralding deteriorating HELLP syndrome (pregnancy hypertension)	7
Corrigendum to “Down-regulation of B2R contributes to preeclampsia by inhibiting human trophoblast cell invasion and angiogenesis” [Pregnancy Hypertens. 21 (2020) 14–22]	7
Barriers and facilitators for adequate calcium intake during pregnancy: A mixed methods study	7
Novel electronic health records applied for prediction of pre-eclampsia: Machine-learning algorithms	7
PO3_11. Elective anticipation of delivery in preeclampsia with cervical preparation by prostaglandins: success for vaginal delivery	7
PO9_13. Towards ‘the best method to determine proteinuria’ in pregnant women	7
Exposure to higher concentrations of exogenous ELABELA causes HTR-8/SVneo trophoblast cell dysfunction: A possible pathogenesis of pre-eclampsia	7
First trimester preeclampsia screening and risk of placental lesions	7
Signs or symptoms of suspected preeclampsia – A retrospective national database study of prevalence, costs, and outcomes	7
PO7_4. Short animated videos aimed at the greatest number of women, to allow and promote self-care in preeclampsia	7
PO1_04. Innovative use of Robson classification to understand prevalence of preeclampsia: findings from a Brazilian survey	7
PO3_09. Inhibition of arginase and supplementation with folic acid decrease ROS production in endothelial cells incubated with plasma from preeclampsia pregnant	7
PO2_07. Metabolic outcomes in women six months and two years after hypertensive versus normotensive pregnancy – a P4 study	7
PLGF – A pioneer in prediction of pre - eclampsia	7

OP04_5. Risk for cardiovascular and cerebrovascular diseases in women during first ten years after pre-eclampsia pregnancy in the FINNPEC study	7
OP08_2. New generation antiplatelet therapies decrease soluble FMS-like tyrosine kinase-1, enhance antioxidant cytoprotection, rescue vascular and endothelial dysfunction and decrease hypertension in	6
Women’s perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia	6
Uterine artery Doppler for the prediction of outcome in pregnancies complicated by hypertensive disorders of pregnancy	6
PO6_20. The SFLT-1/PLGF ratio for the prediction of preeclampsia-related adverse fetal and maternal outcomes in women with preexisting diabetes	6
Increased adherence to ACOG diagnostic guidelines for HDP following a workshop in Bolivia, a LMIC	6
Editorial Board	6
Reference-range of arterial stiffness by cardio-ankle vascular index in normal pregnancy	6
PO8_4. Late postpartum eclampsia with multifocal posterior reversible encephalopathy syndrome after twin gestation: a case report	6
Assessing the Mediterranean diet adherence during pregnancy: Practical considerations based on the associations with cardiometabolic risk	6
First trimester screening (FTS) for placental pathology – Comparison of the efficacy of different methods	5
PO1_16. Changes in early pregnancy blood pressure among nulliparas that developed a hypertensive disorder of pregnancy	5
OP15_5. Metformin to treat preeclampsia: mechanism of action influences mitochondrial dynamics	5
PO1_03. Individual, social, and environmental risk factors for hypertensive disorders of pregnancy in Ghana: A systematic review	5
Impact of Maternal Early Warning Trigger (MEWT) tool on the incidence of eclampsia	5
Preeclampsia and eclampsia: Its burden and distribution across facilities in Ethiopia	5
Diagnostic challenges of Thrombotic Microangiopathy (TMA) in a pregnant woman remote from term and a case report of atypical TTP	5
OP05_4. Umbilical cord plasma from women with pre-eclampsia reduces brain endothelial cell migration involving alterations in the VEGFR2-COFILIN-F-ACTIN polymerization pathway	5
PO8_3. Investigating the role of biomarkers (SFLT-1/PLGF) in cases of covid-19 and its use to distinguish preeclampsia and guide clinical management	5
OP05_5. Characterization of prokineticins receptors anatagonization in preeclampsia: in vitro and in vivo studies	5
Differential effects of renin-angiotensine-aldosteron system inhibition, sympathoinhibition and low sodium diet on blood pressure in women with a history of preeclampsia: A double-blind, placebo-contr	5
Maternal pulmonary hypertension and cardiopulmonary outcomes during delivery hospitalization in the United States: A nationwide study from 2016–2020	5
Eplerenone: A candidate drug to mitigate long-term maternal vascular dysfunction following preeclampsia	5
A study of long-term prognosis after delivery in patients with hypertensive disorders of pregnancy	5
PO3_10. CANCELLED : A randomized controlled trial comparing low doses of aspirin in the prevention of preeclampsia (ASAPP): the first 100 patients	5
A multi-ancestry genome-wide association study identifies novel candidate loci near the RARB gene associated with hypertensive disorders of pregnancy in the personalized environment and genes study	5
PO2_06. Lymphatic mimicry of endothelial cells in utero-placental spiral arteries is impaired by overexpression of HSFLT1 in a murine model for preeclampsia	5
Persistence of abnormal uterine artery flow postpartum: Case-control study	5
Impact of antenatal SARS-CoV-2 infection on development of hypertensive disorders of pregnancy in a large, diverse, cohort	5
Circulating Activin A is elevated at 36 weeks’ gestation preceding a diagnosis of preeclampsia	4
Uterine artery doppler as prognostic indicator in Fetal growth restriction in third trimester	4
Residual liver stiffness in the postpartum period in women with preeclampsia and healthy women: A case-control study	4
Risk factors of preeclampsia among pregnant women admitted at labor ward of public hospitals, low income country of Ethiopia; case control study	4
Letter to the editor: Caution: Not all sFlt-1/PlGF ratios are the same	4
Analyses of selected tumour-associated factors expression in normotensive and preeclamptic placenta	4
PO1_19. Maternal Mortality from Hypertension in Pregnancy in Brazil from 2015 to 2019	4
Is a sFlt-1/PlGF cutoff of 38 suitable to predict adverse outcomes in pregnancies with abnormal uterine artery Doppler velocimetry in the second trimester?	4
Letter to the editor: Is there a relationship between visit-to-visit blood pressure variability and adverse perinatal outcomes?	4
Hypertensive disorders of pregnancy in women with autoimmunity: A rising incidence?	4
Cardiovascular morbidity and mortality following hypertensive disorders of pregnancy	4
SC3_3. FKBPL signalling in placental development and preeclampsia	4
New cardiac platform for the management of cardiovascular risk following preeclampsia using in vitro bioengineered cardiac spheroids and patient-derived stem cells	4
Bioprinting a placental model to study the effects of current and emerging treatments of preeclampsia	4
Hypertension and diabetes risk in patients with previous pregnancy-related disorders and the time to onset of the disease	4
Preeclampsia in women with lupus – Influence of aspirin and hydroxychloroquine on pregnancy outcome	4
Detection of hypertension and blood pressure phenotypes using ambulatory blood pressure monitoring in women with past hypertensive disorders of pregnancies	4
Association of pre-pregnancy subclinical insulin resistance with cardiac dysfunction in healthy nulliparous women	4
Improving treatment of severe hypertension in pregnancy and postpartum using a hypertensive pathway	4
Perspectives of Ghanaian pregnant women on family involvement in home blood pressure Monitoring: A qualitative analysis	4
Blood pressure measurement and adverse pregnancy outcomes – Testing alternatives to 140/90 mmHg	4
Self antenatal monitoring of blood pressure at home as interVention ( SAMBHAV) in hypertensive women: Challenges in the developing country	4
PO2_10. CANCELLED: Maternal vascular malperfusion lesions and preeclampsia are associated with microvascular dysfunction, worse cognition and circulating angiogenic biomarkers 8-10 after pregnancy	3
A tribute to Christopher Redman, MB, BChir, FRCP, FRCOG (ad eundum)	3
OP09_1. Prepare: a stepped wedge cluster randomised trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia	3
Gestational weight gain among gravidae with hypertension receiving labetalol versus nifedipine	3
Cardiovascular mortality risk a decade after twin and singleton pregnancies complicated by hypertensive disorders of pregnancy	3
Clinical study of fundoscopic findings in pregnancy induced hypertension	3
OP07_6. Hydroxychloroquine effect on endothelium – a role in the treatment of preeclampsia?	3
Postpartum readmissions for hypertension in patients discharged on Labetalol and Nifedipine in a Tertiary Care Centre in South India	3
PO9_17. Interventions for improving subject enrollment in RCT	3
OP06_4. Circulating concentrations of glyxocalyx degradation products in preeclampsia	3
Preeclampsia prediction with blood pressure measurements: A global external validation of the ALSPAC models	3
PO1_10. Incidence of prematurity in pregnancies complicated by hypertensive syndromes: A systematic review	3
Preeclampsia, gestational hypertension and incident dementia: A systematic review and meta-analysis of published evidence	3
OP06_5. Alcohol exposure prior to pregnancy - does risk consumption increase the risk of preeclampsia and low birth weight? a swedish population-based cohort study	3
Cardiovascular remodelling and reverse remodelling during pregnancy and postpartum: Looking at the right side	3
No association in maternal serum levels of TMAO and its precursors in pre-eclampsia and in non-complicated pregnancies	3
sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19	3
OP07_4. Aspirin treatment improves reduced uterine perfusion pressure (RUPP)-induced cardiac dysfunction in pregnant rats	3
The significance of mitochondrial haplogroups in preeclampsia risk	3
Racial differences in healthcare utilization among patients with suspected or diagnosed preeclampsia: A retrospective cohort study	3
Elevated expression of galectin-3, thioredoxin and thioredoxin interacting protein in preeclampsia	3
Title Page	3
PO9_07. CANCELLED : Grading the severity of early-onset preeclampsia using parameters considered for indication for delivery: a Delphi consensus	3
Association of fetal sex with angiogenic factors in normotensive and hypertensive pregnancy states	3
Self-monitoring blood pressure in Pregnancy: Evaluation of health professional experiences of the BUMP trials	3
Clinical manifestations and complications of preeclampsia and eclampsia in populations residing at high altitudes and very high altitudes: A scoping review	3
Maternal C1q deficiency leads to impaired hemodynamic adaptations and cardiovascular dysfunction during pregnancy	3
Impact of pregnancy on hypertension and cardiovascular risks among reproductive aged Congolese women: Insights from the 2019 to 2024 May measurement month surveys	3
PO1_11. Optimal timing of antenatal corticosteroid administration in pregnancies complicated by early-onset fetal growth restriction: The opticore study protocol	3

The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice	3
SSRI use in pregnancy: Moving towards collaborative, evidence-based decision-making	3
Editorial Board	2
Placental and serum levels of human α-Klotho in preeclampsia & intra-uterine growth retardation: A potential sensitive biomarker?	2
Nutricional intake, maternal outcomes and knowledge on preeclampsia prevention: Was there impact during the COVID-19 pandemic among women with hypertension?	2
A Randomized control trial to compare the efficacy and Feto-maternal outcome of 75 Mg aspirin versus 150 Mg aspirin in women at high risk of pre-eclampsia	2
Differential platelet activation and thrombo-inflammatory mechanisms in early onset and late onset preeclampsia	2
Association of genetic ancestry with pre-eclampsia in multi-ethnic cohorts of pregnant women	2
Galectin-7 dysregulates renin-angiotensin-aldosterone and NADPH oxide synthase pathways in preeclampsia	2
Substantial decrease in preeclampsia prevalence and risk over two decades: A population-based study of 1,153,227 deliveries in Norway	2
OP04_6. The risk of new-onset neurological disorders after pregnancy-induced hypertension; a nation-wide register-based cohort study	2
Nifedipine and the risk of adverse outcomes in hypertensive pregnancies complicated by fetal growth restriction	2
Circulating cardiovascular biomarkers during and after preeclampsia: Crosstalk with placental function?	2
PO6_11. Clinical value and cost analysis of the SFLT-1/PLGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected preeclampsia: prepare cohort study	2
Differences in disease severity and delivery gestational age between black and white patients with hypertensive disorders of pregnancy	2
Healthcare providers’ knowledge of cardiovascular disease risk after preeclampsia: A pilot of five healthcare facilities in Lusaka, Zambia	2
PO1_07. Non proteinuric preeclampsia: Implications in the diagnosis and clinical and laboratory profile with 2013[StQuote]s new diagnostic criteria	2
OP05_3. Time-of-disease risk prediction of adverse maternal outcomes of pre-eclampsia using artificial intelligence	2
Role of chronic kidney disease and risk factors in preeclampsia	2
Postpartum convulsion – An analysis	2
Low-dose aspirin potentially mitigates placental inflammation by increasing LXA4 and decreasing NLRP3 in an in vitro model of preeclampsia	2
The role of the cerebro-placental-uterine ratio in predicting composite adverse perinatal outcomes in patients with pregnancy-induced hypertension	2
Pre-Eclampsia in pregnancy: A Knowledge, Attitude and Practice (KAP) Survey amongst specialists, junior residents and Primary Care Providers (PCPs) in India	2
Prevalence and risk factors of labor-onset hypertension: A multicenter study in Japan	2
PO3_16. Use of magnesium sulfate in preeclampsia - main maternal side effects	2
Maternal haemodynamic profile in pregnancy after assisted reproductive technology: A pilot study	2
OP19_2. Luteolin, a natural flavonoid, attenuates the development of placental ischemia-induced hypertension in pregnant rats	2
Blood pressure adjustments throughout healthy and hypertensive pregnancy: A systematic review and meta-analysis	2
Clinical presentation and predictors of eclampsia among women with hypertensive disorders of pregnancy in Ghana	2
Prognostic significance of liver function tests in predicting maternal and fetal outcomes in Hypertensive Disorders of Pregnancy	2
Is outpatient surveillance of preeclampsia without severe features still safe in contemporary obese Populations?	2
Factors associated with persistence of hypertension in patients with hypertensive disorders of pregnancy	2
PO8_7. Short-chain fatty acid producing bacteria and butyrate levels are decreased in women who develop preeclampsia throughout gestation	2
Use of non-invasive cardiac monitoring to guide discontinuation of postpartum magnesium sulfate in individuals with preeclampsia with severe features	2
Postpartum clinic attendance, health services utilization and cardiometabolic screening in women with preeclampsia	2
Patients and health care workers perceived challenges in managing preeclampsia, in Malawi	2
Corrigendum to “First trimester preeclampsia screening and risk of placental lesions.” [Pregnancy Hypertens. 41 (2025) 101236]	2
Eclampsia in Italy: A prospective population-based study (2017–2020)	2
Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial	2
Title Page	2
Sleep disordered breathing and the risk of severe maternal morbidity in women with preeclampsia: A population-based study	2
Preeclampsia biomarkers (sFlt-1/PlGF) dynamics are not disrupted by SARS-CoV-2 infection during pregnancy in a hypertensive disorder SARS-CoV-2 vaccinated cohort	2
Intrapartum trends of NT-proBNP and hs-cTnT in patients with severe features of preeclampsia	2